Short Information | AIM ImmunoTech Inc. (NYSE:AIM)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 113,688 |
Total Actual Volume | 5,439,309 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 5,684 |
Average Short Percentage | 2.05% |
Is there a AIM Short Squeeze or Breakout about to happen?
See the AIM Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-26-2024 | $0.36 | $0.3649 | $0.365 | $0.351 | 160,471 | 3 | 0% |
07-25-2024 | $0.3594 | $0.3564 | $0.3599 | $0.3291 | 324,468 | 17,040 | 5.25% |
07-24-2024 | $0.385 | $0.3523 | $0.3999 | $0.351 | 1,104,729 | 30,036 | 2.72% |
07-22-2024 | $0.37 | $0.37 | $0.39 | $0.36 | 233,260 | 4,200 | 1.8% |
07-19-2024 | $0.409 | $0.3703 | $0.42 | $0.37 | 138,667 | 100 | 0.07% |
07-15-2024 | $0.379 | $0.402 | $0.4064 | $0.3663 | 247,498 | 91 | 0.04% |
07-12-2024 | $0.3573 | $0.37 | $0.37 | $0.3573 | 122,847 | 97 | 0.08% |
07-11-2024 | $0.352 | $0.359 | $0.37 | $0.35 | 144,586 | 24,620 | 17.03% |
07-08-2024 | $0.3651 | $0.369 | $0.3779 | $0.36 | 111,452 | 52 | 0.05% |
07-03-2024 | $0.3617 | $0.3838 | $0.389 | $0.3617 | 180,522 | 5,000 | 2.77% |
06-27-2024 | $0.376 | $0.39 | $0.4 | $0.3755 | 57,349 | 100 | 0.17% |
06-26-2024 | $0.3846 | $0.3755 | $0.41 | $0.37 | 341,915 | 1,003 | 0.29% |
06-25-2024 | $0.3914 | $0.3799 | $0.4099 | $0.37 | 261,952 | 376 | 0.14% |
06-21-2024 | $0.3935 | $0.4104 | $0.4104 | $0.391 | 321,100 | 4,920 | 1.53% |
06-20-2024 | $0.39 | $0.3935 | $0.41 | $0.39 | 200,155 | 7,777 | 3.89% |
06-18-2024 | $0.4267 | $0.3973 | $0.4267 | $0.391 | 229,498 | 2,637 | 1.15% |
06-17-2024 | $0.4355 | $0.4251 | $0.45 | $0.4 | 188,234 | 311 | 0.17% |
06-14-2024 | $0.416 | $0.449 | $0.4589 | $0.406 | 422,237 | 11,163 | 2.64% |
06-13-2024 | $0.381 | $0.4111 | $0.415 | $0.3711 | 399,466 | 3,059 | 0.77% |
06-12-2024 | $0.3877 | $0.38275 | $0.39 | $0.36 | 248,903 | 1,103 | 0.44% |
News, Short Squeeze, Breakout and More Instantly...
OCALA, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the publication of new pre-clinical data concerning the company’s drug Ampligen as part of a combinational therapy in the...
OCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Pitch Con...
OCALA, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Lunch Break Series ...